186 related articles for article (PubMed ID: 37971525)
21. [Adjuvant systemic therapy of breast cancer--prognostic and predictive factors].
Rochlitz C
Swiss Surg; 1999; 5(5):222-7. PubMed ID: 10546521
[TBL] [Abstract][Full Text] [Related]
22. The impact of new systemic therapies on survival and time on hormonal treatment in hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: A population-based study in British Columbia from 2003 to 2013.
Le D; Speers C; Thompson L; Gondara L; Nichol A; Lohrisch C
Cancer; 2020 Mar; 126(5):971-977. PubMed ID: 31750938
[TBL] [Abstract][Full Text] [Related]
23. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review.
Kobayashi T; Ichiba T; Sakuyama T; Arakawa Y; Nagasaki E; Aiba K; Nogi H; Kawase K; Takeyama H; Toriumi Y; Uchida K; Kobayashi M; Kanehira C; Suzuki M; Ando N; Natori K; Kuraishi Y
Breast Cancer; 2012 Jul; 19(3):218-37. PubMed ID: 22532161
[TBL] [Abstract][Full Text] [Related]
24. [Metastatic breast cancer: what are the objectives?].
Salvini P; Ripa C; Ginanni V
Tumori; 2000; 86(5 Suppl 1):S22-8. PubMed ID: 11195289
[TBL] [Abstract][Full Text] [Related]
25. Early Recognition and Management of Side Effects Related to Systemic Anticancer Therapy for Advanced Breast Cancer.
Diez de Los Rios de la Serna C; Boers-Doets CB; Wiseman T; Radia B; Hammond R
Semin Oncol Nurs; 2024 Feb; 40(1):151553. PubMed ID: 38171975
[TBL] [Abstract][Full Text] [Related]
26. Management of locally advanced breast cancer. Mini-review.
Franceschini G; Terribile D; Fabbri C; Magno S; D'Alba P; Chiesa F; Di Leone A; Masetti R
Minerva Chir; 2007 Aug; 62(4):249-55. PubMed ID: 17641585
[TBL] [Abstract][Full Text] [Related]
27. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
28. [Systemic chemotherapy and breast cancer].
Collignon J; Rorive A; Martin M; Andre C; Maweja S; Lifrange E; Coucke P; Jerusalem G
Rev Med Liege; 2011; 66(5-6):372-8. PubMed ID: 21826979
[TBL] [Abstract][Full Text] [Related]
29. Ophthalmic Metastasis of Breast Cancer and Ocular Side Effects from Breast Cancer Treatment and Management: Mini Review.
Georgalas I; Paraskevopoulos T; Koutsandrea C; Kardara E; Malamos P; Ladas D; Papaconstantinou D
Biomed Res Int; 2015; 2015():574086. PubMed ID: 26078956
[TBL] [Abstract][Full Text] [Related]
30. Surgery for breast cancer.
Dooley WC
Curr Opin Oncol; 1998 Nov; 10(6):504-12. PubMed ID: 9818228
[TBL] [Abstract][Full Text] [Related]
31. [Chinese expert consensus on the clinical diagnosis and treatment of advanced breast carcinoma(2018)].
Chinese Anti-Cancer Association, Committee of Breast Cancer Society
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):703-713. PubMed ID: 30293398
[TBL] [Abstract][Full Text] [Related]
32. Metaplastic breast cancer: clinical overview and molecular aberrations for potential targeted therapy.
Abouharb S; Moulder S
Curr Oncol Rep; 2015 Mar; 17(3):431. PubMed ID: 25691085
[TBL] [Abstract][Full Text] [Related]
33. The role of chemotherapy and targeted agents in patients with metastatic breast cancer.
Johnston SR
Eur J Cancer; 2011 Sep; 47 Suppl 3():S38-47. PubMed ID: 21944023
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update.
Arslan C; Dizdar O; Altundag K
Expert Opin Pharmacother; 2014 Aug; 15(12):1643-58. PubMed ID: 25032884
[TBL] [Abstract][Full Text] [Related]
35. Metastatic breast cancer: an updating.
Nicolini A; Giardino R; Carpi A; Ferrari P; Anselmi L; Colosimo S; Conte M; Fini M; Giavaresi G; Berti P; Miccoli P
Biomed Pharmacother; 2006 Nov; 60(9):548-56. PubMed ID: 16950593
[TBL] [Abstract][Full Text] [Related]
36. Systemic therapy of metastatic breast cancer: a review of the current trends.
Legha SS; Blumenschein GR
Oncology; 1982; 39(3):140-5. PubMed ID: 7078937
[TBL] [Abstract][Full Text] [Related]
37. Implications of the new biology for therapy in breast cancer.
Sledge GW
Semin Oncol; 1996 Feb; 23(1 Suppl 2):76-81. PubMed ID: 8614850
[TBL] [Abstract][Full Text] [Related]
38. Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer.
Cardoso F; Di Leo A; Piccart MJ
Cancer Treat Rev; 2002 Dec; 28(6):275-90. PubMed ID: 12470979
[TBL] [Abstract][Full Text] [Related]
39. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
40. Management of Brain and Leptomeningeal Metastases from Breast Cancer.
Pellerino A; Internò V; Mo F; Franchino F; Soffietti R; Rudà R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
